Konidaris Tasos (CIK 1320982) reported 24 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-05). Recent activity: Buy AMRX (45,290 shares), Sell AMRX (16,182 shares), Buy AMRX (57,339 shares), Sell AMRX (24,251 shares), Buy AMRX (28,538 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Buy | 45,290 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Sell | 16,182 | $215,382 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Buy | 57,339 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Sell | 24,251 | $322,781 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Buy | 28,538 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Sell | 14,298 | $190,306 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Buy | 458,716 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Sell | 229,817 | $3.1M |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Buy | 43,982 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Sell | 22,035 | $293,066 |
| 2025-08-15 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Sell | 219,159 | $2.1M |
| 2025-08-15 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Sell | 119,206 | $1.1M |
| 2025-08-15 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Sell | 161,365 | $1.5M |
| 2025-03-07 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Sell | 100,000 | $891,000 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Buy | 45,290 | $0 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Sell | 16,373 | $143,427 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Buy | 57,340 | $0 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Sell | 24,374 | $213,516 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Buy | 181,159 | $0 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Sell | 92,663 | $811,728 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Buy | 43,981 | $0 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Sell | 22,497 | $198,873 |
| 2025-03-04 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Buy | 36,197 | $0 |
| 2025-03-04 | Amneal Pharmaceuticals, Inc. (AMRX) | Executive Vice President & CFO | Sell | 13,494 | $116,993 |
Source: SEC Form 4 filings · as of 2026-03-05